March 22, 2026 a 11:43 am
SYK: Fundamental Ratio Analysis - Stryker Corporation
Stryker Corporation has a robust presence in the medical technology sector, characterized by steady growth and strong market positioning. The company's diverse product segments cater to critical healthcare needs, ensuring reliable business longevity. However, the volatility of the healthcare sector presents both opportunities and risks for potential investors.
Fundamental Rating
The fundamental rating for Stryker Corporation reflects a solid performance in critical financial metrics, albeit with room for improvement in leverage ratios.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical scores demonstrate minor fluctuations over recent periods, maintaining a generally stable performance.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | 3 | 4 | 4 | 4 | 1 | 1 | 1 |
| N/A | 0 | 4 | 4 | 4 | 1 | 1 | 1 |
Analyst Price Targets
Analyst estimates indicate a positive outlook with a high degree of confidence in target prices, signaling potential value growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| 469 | 390 | 426.5 | 428.67 |
Analyst Sentiment
Overall analyst sentiment towards Stryker Corporation shows a favorable trend with a strong inclination towards Buy recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 35 | |
| Hold | 14 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Stryker Corporation presents a compelling investment opportunity, driven by its leadership in medical technology and diversified product offerings. With favorable analyst projections and a solid financial foundation, the company's long-term growth prospects remain robust. Potential risks include industry competition and economic fluctuations affecting healthcare spending. Overall, Stryker maintains a promising outlook for growth and value appreciation.